
Novel Cellular Therapies in Autoimmune Rheumatic Diseases
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode of HSS Presents, Dr. Mary “Peggy” Crow hosts a compelling discussion with Drs. Kyriakos Kirou and Robert Spiera on cutting-edge cellular therapies transforming the treatment of autoimmune rheumatic diseases. The panel delves into the science and clinical promise of CAR T-cell therapy and bispecific T-cell engagers (BiTEs), exploring how these oncology-derived approaches are being applied to conditions like lupus, scleroderma, myositis, and ANCA-associated vasculitis. They discuss the mechanisms of action, safety considerations, and patient selection, while also highlighting the goal of achieving long-term, drug-free remission through immune system “reset.” This thought-provoking episode offers a glimpse into the future of precision immunology and the evolving role of living cellular therapies in rheumatology.